Orasure Technologies Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
2analysts covering
FY Revenue (est.)
$119.7Mnext fiscal year
FY EPS (est.)
-$0.70next fiscal year
Monitoring Framework
Key Performance Indicators
Core Revenue Quarterly27.9MTarget: 27000000 to 30000000
GAAP Gross Margin Quarterly42.3%
Watch Items
- FDA Clearance for Rapid Molecular STI Self-TestTrigger: Mid-2026Action: Monitor regulatory announcements and subsequent commercial launch timeline in H2 2026
- Operating Loss StabilizationTrigger: GAAP Operating Loss of $23.3 million in Q1 2026Action: Track progress of insourcing production to Pennsylvania facilities to drive operational efficiencies
Research as of 20 Jun 2026